6599 AEON
- 1.490
- -0.040-2.61%
AEON News
J.P. Morgan Reaffirms Their Sell Rating on AEON Co (AONNF)
Aeon Thana Sinsap (Thailand) Raised to Buy From Hold by UOB Kay Hian >AEONTS.TH
Aeon Thana Sinsap (Thailand) Target Price Raised to THB158.00 From THB150.00 by UOB Kay Hian >AEONTS.TH
Aeon Co.(M) Target Price Raised to MYR1.95 From MYR1.86 by Maybank IB >6599.KU
AEON Biopharma Price Target Maintained With a $5.00/Share by HC Wainwright & Co.
Buy Rating on AEON Biopharma: Strategic FDA Alignment and Positive Long-Term Revenue Projections
AEON Thana Sinsap (Thailand) Target Price Raised to THB150.00 From THB148.00 by UOB Kay Hian >AEONTS.TH
AEON Biopharma Price Target Cut to $5.00/Share From $6.00 by HC Wainwright & Co.
Buy Rating Affirmed for AEON Biopharma on Strategic Biosimilar Pathway and Promising Phase 3 Study Prospects
Buy Rating Affirmed for AEON Biopharma: Strategic Cost-Cutting and ABP-450's Broad Market Potential
HC Wainwright & Co. : The AEON Biopharma (AEON.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $18.00 to $6.00.
Analysts Are Bullish on These Healthcare Stocks: AEON Biopharma (AEON), Palatin Technologies (PTN)
HC Wainwright & Co. : The AEON Biopharma (AEON.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $18.00.
AEON Biopharma Analyst Ratings
HC Wainwright & Co. Reiterates Buy on AEON Biopharma, Maintains $18 Price Target
Analysts Have Conflicting Sentiments on These NA Companies: Digital Realty (DLR) and AEON Biopharma (AEON)
HC Wainwright & Co. Initiates Coverage On AEON Biopharma With Buy Rating, Announces Price Target of $18
AEON Biopharma Analyst Ratings
No Data